Healthcare Global Enterprises Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) & 31(5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.2 pts more than Nifty Microcap 250 and 0.7 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Dr. B.S. Ajaikumar, the Promoter of Healthcare Global Enterprises, has filed a declaration under SEBI Takeover Regulations disclosing share encumbrances for FY 2024-25. During the year, he encumbered 18,92,539 equity shares on March 12, 2025, which was already disclosed to stock exchanges on March 17, 2025. Including prior encumbrances from FY 2020-21 (29,77,000 shares) and FY 2022-23 (90,000 shares), total encumbered shares stand at 49,59,539, representing 3.56% of the company's paid-up capital as of March 31, 2025. No other encumbrances were made by the promoter or persons acting in concert during the year.
The promoter has pledged 3.56% of paid-up capital, which is a moderate level and not a major concern. Investors should monitor for any further encumbrances or invocation, as increased pledging can signal financial stress. The fact that this is a routine annual declaration with no new large-scale pledging is mildly reassuring.